Position in CDXS
as of Mar 31, 2026
· filed Aug 7, 2026
Position Value
$1,594,255
+$0 QoQ
Shares Held
978,071
0.0% QoQ
Ownership
0.893%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Timothy G. Youngquist 2020 Irrevocable Trust holds $46,702,441 across 5 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CHRS |
Coherus Oncology, Inc.
|
13,050,623 | $18,270,872 | |
| 2 | RLAY |
Relay Therapeutics, Inc.
|
801,464 | $14,995,391 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
271,849 | $10,604,829 | |
| 4 | MLYS |
Mineralys Therapeutics, Inc.
|
100,869 | $2,721,445 | |
| 5 | CNTX |
Context Therapeutics Inc.
|
198,384 | $109,904 |
All Filings in CDXS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,594,255 | 978,071 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $1,594,255 | 978,071 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||